Skip to main content
Fig. 2 | Journal of Pharmaceutical Health Care and Sciences

Fig. 2

From: Factors influencing the effectiveness of recombinant human soluble thrombomodulin on disseminated intravascular coagulation: a retrospective study

Fig. 2

28-day survival curves after rTM in patients with PT-INR ≥ 1.67 and PT-INR < 1.67. The survival rate of patients with PT-INR < 1.67 was significantly higher than that of patients with PT-INR ≥ 1.67 (p < 0.001). PT-INR, prothrombin time-international normalized ratio; rTM, recombinant human soluble thrombomodulin

Back to article page

Journal of Pharmaceutical Health Care and Sciences

ISSN: 2055-0294

Contact us